Circulating tumor cell (CTC) genomic signatures of hormone therapy resistance in men with metastatic castration-resistant prostate cancer (mCRPC)

被引：0
|
作者：
Gupta, Santosh
Halabi, Susan
Kemeny, Gabor
Anand, Monika
Nanus, David M.
Giannakakou, Paraskevi
George, Daniel J.
Gregory, Simon
Armstrong, Andrew J.
机构：
[1] Duke Univ, Duke Canc Inst, Durham, NC USA
[2] Duke Univ, Med Ctr, Durham, NC USA
[3] Duke Univ, Durham, NC USA
[4] Sandra & Edward Meyer Canc Ctr, New York, NY USA
[5] Weill Cornell Med, Meyer Canc Ctr, New York, NY USA
[6] Duke Univ, Sch Med, Durham, NC USA
[7] Duke Canc Inst, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
147
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Predictive biomarkers in circulating tumor cells to direct management metastatic castration-resistant prostate cancer (mCRPC)
    Scher, Howard I.
    Schonhoft, Joseph
    Dittamore, Ryan
    CANCER RESEARCH, 2019, 79 (13)
  • [32] Molecular characterization of circulating tumor cells (CTC) and CTC. subpopulations in baseline and progressive metastatic castration resistant prostate cancer (mCRPC)
    Dittamore, Ryan
    Louw, Jessica
    Krupa, Rachel
    Danila, Daniel Costin
    Arslan, Zaina
    Schreiber, Nicole A.
    Bales, Natalee
    Marrinucci, Dena
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [33] Bipolar androgen therapy (BAT) plus olaparib in men with metastatic castration-resistant prostate cancer (mCRPC)
    Schweizer, M.
    Gulati, R.
    Yezefski, T.
    Cheng, H.
    Sievers, C.
    Dumpit, R.
    Alexander, K.
    McDonald, N.
    Lai, M.
    Nega, K.
    Hammond, J.
    Grivas, P.
    Hsieh, A.
    Montgomery, B.
    Nelson, P.
    Yu, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S639 - S640
  • [34] Heterogeneity of prostate-specific membrane antigen (PSMA) expression in classic and apoptotic circulating tumor cells (CTC) in metastatic castration-resistant prostate cancer (mCRPC)
    Autio, Karen A.
    Anand, Aseem
    Krupa, Rachel
    Louw, Jessica
    Arslan, Zaina
    Dittamore, Ryan
    Scher, Howard I.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [35] Biomarker-directed therapy in black and white men with metastatic castration-resistant prostate cancer (mCRPC).
    Hwang, Clara
    Henderson, Nicholas
    Cackowski, Frank Cameron
    Pilling, Amanda
    Jang, Albert
    Rothstein, Shoshana
    Labriola, Matthew
    Park, Joseph J.
    Ghose, Alyssa
    Bilen, Mehmet Asim
    Kilari, Deepak
    Tripathi, Abhishek
    Garje, Rohan
    Koshkin, Vadim S.
    Schweizer, Michael Thomas
    Armstrong, Andrew J.
    Mckay, Rana R.
    Dorff, Tanya B.
    Alva, Ajjai Shivaram
    Barata, Pedro C.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [36] Circulating tumor (ct)-DNA alterations in metastatic castration-resistant prostate cancer (mCRPC): Association with outcomes and evolution with therapy.
    Sonpavde, Guru
    Nagy, Rebecca J.
    Sartor, A. Oliver
    Pond, Gregory Russell
    Gourdin, Theodore Stewart
    Nandagopal, Lakshminarayanan
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [37] Impact of temsirolimus and anti-androgen therapy on circulating tumor cell (CTC) biology in men with castration-resistant metastatic prostate cancer (CRPC): A phase II study
    Armstrong, A. J.
    Kemeny, G.
    Turnbull, J. D.
    Chao, C.
    Winters, C.
    Fesko, Y. A.
    Bradley, D. A.
    Halabi, S.
    George, D. J.
    Garcia-Blanco, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [38] Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer (mCRPC).
    Maughan, Benjamin Louis
    Suzman, Daniel L.
    Nadal, Rosa
    Bassi, Sunakshi
    Schweizer, Michael Thomas
    Antonarakis, Emmanuel S.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [39] Body composition and clinical outcomes in men with metastatic castration-resistant prostate cancer (mCRPC)
    Hahn, A. W.
    Tidwell, R. S.
    Surasi, D. S.
    Msaouel, P.
    Efstathiou, E.
    Zurita-Saavedra, A. J.
    Tu, S-M.
    McQuade, J. L.
    Fogelman, D.
    Starbuck, M. W.
    Subudhi, S. K.
    Corn, P.
    Pilie, P. G.
    Aparicio, A.
    Logothetis, C.
    ANNALS OF ONCOLOGY, 2020, 31 : S538 - S538
  • [40] The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide
    Halabi, Susan
    Guo, Siyuan
    Park, Joseph J.
    Nanus, David M.
    George, Daniel J.
    Antonarakis, Emmanuel S.
    Danila, Daniel Costin
    Szmulewitz, Russell Zelig
    Mcdonnell, Donald P.
    Norris, John D.
    Lu, Changxue
    Luo, Jun
    Armstrong, Andrew J.
    CLINICAL CANCER RESEARCH, 2024, 30 (06) : 1152 - 1159
12345